BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo C, Li L, Yang X, Meng Z, Li F, Zhang C, Yang Z. Protective effects of timosaponin B-II on high glucose-induced apoptosis in human umbilical vein endothelial cells. Environmental Toxicology and Pharmacology 2014;37:37-44. [DOI: 10.1016/j.etap.2013.11.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou F, Liu BF, Wang C, Zhang J, Dong GM, Jin HT, Ma BP, Zhong XM. Acute toxicity, 28-day repeated-dose toxicity and toxicokinetic study of timosaponin BII in beagle dogs. J Asian Nat Prod Res 2021;:1-17. [PMID: 34698619 DOI: 10.1080/10286020.2021.1993834] [Reference Citation Analysis]
2 Jiménez GG, Durán AG, Macías FA, Simonet AM. Structure, Bioactivity and Analytical Methods for the Determination of Yucca Saponins. Molecules 2021;26:5251. [PMID: 34500685 DOI: 10.3390/molecules26175251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu S, Wang X, Zou K, Liu W, Li C, Zheng Y, Zhou Q, Peng G. Simultaneous Determination of Eight Potential Q-Markers in Zishen Tongguan Capsules Based on UHPLC-MS/MS. CPA 2020;17:47-56. [DOI: 10.2174/1573412915666190522081113] [Reference Citation Analysis]
4 Xing N, Wang Y, Wang W, Zhong R, Xia T, Ding Z, Yang Y, Zhong Y, Shu Z. Cardioprotective effect exerted by Timosaponin BⅡ through the regulation of endoplasmic stress-induced apoptosis. Phytomedicine 2020;78:153288. [PMID: 32782218 DOI: 10.1016/j.phymed.2020.153288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chen W, Li R, Zhu S, Ma J, Pang L, Ma B, Du L, Jin Y. Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer's disease induced by lipopolysaccharides. Int J Pharm 2020;578:119115. [PMID: 32045690 DOI: 10.1016/j.ijpharm.2020.119115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
6 Lin N, Liu B, Zhang J, Long Y, Dong G, Jin H, Ma B. Acute toxicity, 28-day repeated-dose toxicity and toxicokinetic study of timosaponin BII in rats. Regul Toxicol Pharmacol 2017;90:244-57. [PMID: 28947379 DOI: 10.1016/j.yrtph.2017.09.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Sun X, Zhu F, Zhang Y, Chen F, Yu Y, Song N, Huang X. Two new steroidal saponins isolated from Anemarrhena asphodeloides. Chinese Journal of Natural Medicines 2017;15:220-4. [DOI: 10.1016/s1875-5364(17)30038-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Yang BY, Zhang J, Liu Y, Kuang HX. Steroidal Saponins from the Rhizomes of Anemarrhena asphodeloides. Molecules 2016;21:E1075. [PMID: 27548119 DOI: 10.3390/molecules21081075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
9 Qin W, Ren B, Wang S, Liang S, He B, Shi X, Wang L, Liang J, Wu F. Apigenin and naringenin ameliorate PKCβII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. Vascul Pharmacol 2016;85:39-49. [PMID: 27473516 DOI: 10.1016/j.vph.2016.07.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
10 Zhao Y, Jiang T, Han B, Lu L, Feng B, Kang L, Zhang J, Fang Y, Xiong C, Jia D, Ma B. Preparation of some metabolites of timosaponin BII by biotransformation in vitro. Process Biochemistry 2015;50:2182-7. [DOI: 10.1016/j.procbio.2015.09.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
11 Zhao H, Ma T, Fan B, Yang L, Han C, Luo J, Kong L. Protective effect of trans-δ-viniferin against high glucose-induced oxidative stress in human umbilical vein endothelial cells through the SIRT1 pathway. Free Radic Res 2016;50:68-83. [PMID: 26483208 DOI: 10.3109/10715762.2015.1108412] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
12 Deng XY, Chen JJ, Li HY, Ma ZQ, Ma SP, Fu Q. Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats. Chem Biol Interact 2015;240:22-8. [PMID: 26277537 DOI: 10.1016/j.cbi.2015.08.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
13 Tan S, Zhao H, Luo J, Kong L. Triterpenes and triterpene glucosides with their oxidative stress injury protective activity from Rubus lambertianus. Phytochemistry Letters 2015;12:1-5. [DOI: 10.1016/j.phytol.2015.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Huo Z, Qiu Y, Chu Z, Yin P, Lu W, Yan Y, Wan N, Chen Z. Electrospinning Preparation of Timosaponin B-II-Loaded PLLA Nanofibers and Their Antitumor Recurrence Activities In Vivo. Journal of Nanomaterials 2015;2015:1-9. [DOI: 10.1155/2015/367964] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
15 Jiang SH, Shang L, Xue LX, Ding W, Chen S, Ma RF, Huang JF, Xiong K. The effect and underlying mechanism of Timosaponin B-II on RGC-5 necroptosis induced by hydrogen peroxide. BMC Complement Altern Med 2014;14:459. [PMID: 25439561 DOI: 10.1186/1472-6882-14-459] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sheng J, Tian X, Xu G, Wu Z, Chen C, Wang L, Pan L, Huang C, Pan G. The Hepatobiliary Disposition of Timosaponin B2 Is Highly Dependent on Influx/Efflux Transporters but Not Metabolism. Drug Metab Dispos 2014;43:63-72. [DOI: 10.1124/dmd.114.059923] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
17 Kosova F, Temeltaş G, Arı Z, Lekili M. Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients. Tumour Biol 2014;35:4295-9. [PMID: 24375255 DOI: 10.1007/s13277-013-1560-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]